172 related articles for article (PubMed ID: 38577851)
1. A biomimetic camouflaged metal organic framework for enhanced siRNA delivery in the tumor environment.
Tao T; Rehman SU; Xu S; Zhang J; Xia H; Guo Z; Li Z; Ma K; Wang J
J Mater Chem B; 2024 May; 12(17):4080-4096. PubMed ID: 38577851
[TBL] [Abstract][Full Text] [Related]
2. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy.
Huang X; Guo H; Wang L; Zhang Z; Zhang W
Drug Discov Today; 2023 Apr; 28(4):103514. PubMed ID: 36736580
[TBL] [Abstract][Full Text] [Related]
3. Construction of Biomimetic-Responsive Nanocarriers and their Applications in Tumor Targeting.
Tian X; Shi A; Wu J
Anticancer Agents Med Chem; 2022; 22(12):2255-2273. PubMed ID: 34994336
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
5. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
[TBL] [Abstract][Full Text] [Related]
6. Biomedical application of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targeted delivery, phototherapy and diagnosis.
Li B; Ashrafizadeh M; Jiao T
Int J Biol Macromol; 2024 Mar; 260(Pt 2):129391. PubMed ID: 38242413
[TBL] [Abstract][Full Text] [Related]
7. Efficient nanocarriers of siRNA therapeutics for cancer treatment.
Subhan MA; Torchilin VP
Transl Res; 2019 Dec; 214():62-91. PubMed ID: 31369717
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in cell membrane coated metal-organic frameworks (MOFs) for tumor therapy.
Liu W; Yan Q; Xia C; Wang X; Kumar A; Wang Y; Liu Y; Pan Y; Liu J
J Mater Chem B; 2021 Jun; 9(22):4459-4474. PubMed ID: 33978055
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.
Zhang P; An K; Duan X; Xu H; Li F; Xu F
Drug Discov Today; 2018 Apr; 23(4):900-911. PubMed ID: 29373841
[TBL] [Abstract][Full Text] [Related]
10. Novel formulations of metal-organic frameworks for controlled drug delivery.
Rao C; Liao D; Pan Y; Zhong Y; Zhang W; Ouyang Q; Nezamzadeh-Ejhieh A; Liu J
Expert Opin Drug Deliv; 2022 Oct; 19(10):1183-1202. PubMed ID: 35426756
[TBL] [Abstract][Full Text] [Related]
11. Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins.
Cheng G; Li W; Ha L; Han X; Hao S; Wan Y; Wang Z; Dong F; Zou X; Mao Y; Zheng SY
J Am Chem Soc; 2018 Jun; 140(23):7282-7291. PubMed ID: 29809001
[TBL] [Abstract][Full Text] [Related]
12. Regulating the immunosuppressive tumor microenvironment to enhance breast cancer immunotherapy using pH-responsive hybrid membrane-coated nanoparticles.
Gong C; Yu X; Zhang W; Han L; Wang R; Wang Y; Gao S; Yuan Y
J Nanobiotechnology; 2021 Feb; 19(1):58. PubMed ID: 33632231
[TBL] [Abstract][Full Text] [Related]
13. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
[TBL] [Abstract][Full Text] [Related]
14. The potential and advances in RNAi therapy: chemical and structural modifications of siRNA molecules and use of biocompatible nanocarriers.
Joo MK; Yhee JY; Kim SH; Kim K
J Control Release; 2014 Nov; 193():113-21. PubMed ID: 24862319
[TBL] [Abstract][Full Text] [Related]
15. Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells.
Oliveira AC; Raemdonck K; Martens T; Rombouts K; Simón-Vázquez R; Botelho C; Lopes I; Lúcio M; González-Fernández Á; Real Oliveira ME; Gomes AC; Braeckmans K
Acta Biomater; 2015 Oct; 25():216-29. PubMed ID: 26225736
[TBL] [Abstract][Full Text] [Related]
16. Targeted gene silencing in vivo by platelet membrane-coated metal-organic framework nanoparticles.
Zhuang J; Gong H; Zhou J; Zhang Q; Gao W; Fang RH; Zhang L
Sci Adv; 2020 Mar; 6(13):eaaz6108. PubMed ID: 32258408
[TBL] [Abstract][Full Text] [Related]
17. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
[TBL] [Abstract][Full Text] [Related]
18. Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.
Lu M; Zhao X; Xing H; Liu H; Lang L; Yang T; Xun Z; Wang D; Ding P
Acta Biomater; 2019 Sep; 96():517-536. PubMed ID: 31284098
[TBL] [Abstract][Full Text] [Related]
19. Silencing of Pyruvate Kinase M2
Huang S; Zhu W; Zhang F; Chen G; Kou X; Yang X; Ouyang G; Shen J
ACS Appl Mater Interfaces; 2021 Dec; 13(48):56972-56987. PubMed ID: 34797638
[TBL] [Abstract][Full Text] [Related]
20. Nanocarriers in effective pulmonary delivery of siRNA: current approaches and challenges.
Bardoliwala D; Patel V; Javia A; Ghosh S; Patel A; Misra A
Ther Deliv; 2019 May; 10(5):311-332. PubMed ID: 31116099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
